Katharina Prieske

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

Philipp Harter, Jan Hauke, Florian Heitz et al. · PLoS ONE · 2017 · 133 citations · Full text

Life Sciences, Genetics, Oncology +17

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

Mark Tuthill, Antonella Montinaro, Julia Zinngrebe et al. · Oncogene · 2014 · 74 citations

Medicine, Cancer Biology, Oncology +13

Patterns of distant metastases in vulvar cancer

Katharina Prieske, Nicole Haeringer, Donata Grimm et al. · Gynecologic Oncology · 2016 · 55 citations

Medicine, Oncology, Pathology +14

E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer

Fabian Trillsch, Sascha Kuerti, Christine Eulenburg et al. · British Journal of Cancer · 2016 · 44 citations · Full text

Medicine, Oncology, Pathology +17

p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group

Linn Woelber, Katharina Prieske, Christine zu Eulenburg et al. · American Journal of Obstetrics and Gynecology · 2021 · 44 citations · Full text

Medicine, Oncology, Radiation Oncology +16